170 related articles for article (PubMed ID: 33101778)
1. Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis.
Nugteren S; Goos JACM; Delis-van Diemen PM; Simons-Oosterhuis Y; Lindenbergh-Kortleve DJ; van Haaften DH; Sanders J; Meijer GA; Fijneman RJA; Samsom JN
Oncoimmunology; 2020 Oct; 9(1):1832761. PubMed ID: 33101778
[TBL] [Abstract][Full Text] [Related]
2. High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence.
Nugteren S; den Uil SH; Delis-van Diemen PM; Simons-Oosterhuis Y; Lindenbergh-Kortleve DJ; van Haaften DH; Stockmann HBAC; Sanders J; Meijer GA; Fijneman RJA; Samsom JN
Sci Rep; 2022 Jul; 12(1):12174. PubMed ID: 35842496
[TBL] [Abstract][Full Text] [Related]
3. Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications.
Zhang X; Liu SS; Ma J; Qu W
Pathol Res Pract; 2023 Aug; 248():154633. PubMed ID: 37356220
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
[TBL] [Abstract][Full Text] [Related]
5. Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer.
Nugteren S; Samsom JN
Cytokine Growth Factor Rev; 2021 Jun; 59():22-35. PubMed ID: 33602652
[TBL] [Abstract][Full Text] [Related]
6. Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer.
Liu G; Yang J; Zhao Y; Wang Z; Xing B; Wang L; Shi D
World J Surg Oncol; 2014 Dec; 12():369. PubMed ID: 25441765
[TBL] [Abstract][Full Text] [Related]
7. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
Mikami Y; Iwase T; Komiyama Y; Matsumoto N; Oki H; Komiyama K
Mol Immunol; 2015 Oct; 67(2 Pt B):568-74. PubMed ID: 26239418
[TBL] [Abstract][Full Text] [Related]
8. Human buccal epithelium acquires microbial hyporesponsiveness at birth, a role for secretory leukocyte protease inhibitor.
Menckeberg CL; Hol J; Simons-Oosterhuis Y; Raatgeep HR; de Ruiter LF; Lindenbergh-Kortleve DJ; Korteland-van Male AM; El Aidy S; van Lierop PP; Kleerebezem M; Groeneweg M; Kraal G; Elink-Schuurman BE; de Jongste JC; Nieuwenhuis EE; Samsom JN
Gut; 2015 Jun; 64(6):884-93. PubMed ID: 25056659
[TBL] [Abstract][Full Text] [Related]
9. Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier.
Ozaka S; Sonoda A; Ariki S; Kamiyama N; Hidano S; Sachi N; Ito K; Kudo Y; Minata M; Saechue B; Dewayani A; Chalalai T; Soga Y; Takahashi Y; Fukuda C; Mizukami K; Okumura R; Kayama H; Murakami K; Takeda K; Kobayashi T
Genes Cells; 2021 Oct; 26(10):807-822. PubMed ID: 34379860
[TBL] [Abstract][Full Text] [Related]
10. Endogenous secretory leukocyte protease inhibitor inhibits microbial-induced monocyte activation.
Nugteren S; Simons-Oosterhuis Y; Menckeberg CL; Hulleman-van Haaften DH; Lindenbergh-Kortleve DJ; Samsom JN
Eur J Immunol; 2023 Feb; 53(2):e2249964. PubMed ID: 36480463
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of secretory leukocyte protease inhibitor (SLPI) promotes the PUMA-mediated apoptosis and chemosensitivity to cisplatin in colorectal cancer cells.
Wei Z; Liu G; Jia R; Zhang W; Li L; Zhang Y; Wang Z; Bai X
Discov Oncol; 2023 Jan; 14(1):1. PubMed ID: 36595102
[TBL] [Abstract][Full Text] [Related]
12. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
Noorlag R; van der Groep P; Leusink FK; van Hooff SR; Frank MH; Willems SM; van Es RJ
Head Neck; 2015 Aug; 37(8):1130-6. PubMed ID: 24764155
[TBL] [Abstract][Full Text] [Related]
13. Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.
Svensson D; Aidoukovitch A; Anders E; Jönsson D; Nebel D; Nilsson BO
Inflamm Res; 2017 Sep; 66(9):823-831. PubMed ID: 28597116
[TBL] [Abstract][Full Text] [Related]
14. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F
Gene; 2019 Dec; 720():144088. PubMed ID: 31476404
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.
Hoffmann M; Quabius ES; Tribius S; Hebebrand L; Görögh T; Halec G; Kahn T; Hedderich J; Röcken C; Haag J; Waterboer T; Schmitt M; Giuliano AR; Kast WM
Oncol Rep; 2013 May; 29(5):1962-8. PubMed ID: 23467841
[TBL] [Abstract][Full Text] [Related]
16. The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway.
Sugino T; Yamaguchi T; Ogura G; Kusakabe T; Goodison S; Homma Y; Suzuki T
J Pathol; 2007 Jun; 212(2):152-60. PubMed ID: 17455170
[TBL] [Abstract][Full Text] [Related]
17. Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer.
Zheng D; Gui B; Gray KP; Tinay I; Rafiei S; Huang Q; Sweeney CJ; Kibel AS; Jia L
Oncogene; 2016 Sep; 35(36):4807-15. PubMed ID: 26876202
[TBL] [Abstract][Full Text] [Related]
18. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo.
Devoogdt N; Rasool N; Hoskins E; Simpkins F; Tchabo N; Kohn EC
Cancer Sci; 2009 Mar; 100(3):434-40. PubMed ID: 19154415
[TBL] [Abstract][Full Text] [Related]
20. Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells.
Si-Tahar M; Merlin D; Sitaraman S; Madara JL
Gastroenterology; 2000 Jun; 118(6):1061-71. PubMed ID: 10833481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
